Epigenetic Health Benefits of Budesonide
Latest Information Update: 31 Mar 2025
At a glance
- Drugs Budesonide (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Acronyms Project Ace
Most Recent Events
- 27 Mar 2025 Planned End Date changed from 31 Dec 2025 to 31 Dec 2027.
- 27 Mar 2025 Planned primary completion date changed from 31 Dec 2024 to 31 Dec 2025.
- 28 Mar 2024 Planned End Date changed from 31 Dec 2024 to 31 Dec 2025.